Thomas Schurpf,Abhishek Datta,Gregory J. Carven,Constance Martin,Ashish Kalra,Kimberly Long,Alan Buckler
申请号：
US15863564
公开号：
US20180207267A1
申请日:
2018.01.05
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Disclosed herein are therapeutic use of isoform-specific, context-permissive inhibitors of TGFβ1 in the treatment of disease that involve TGFβ1 dysregulation.
